AMGEN
- Country
- Belgium
- Type
- Beneficiary
- Grants received
- 8
Funding record
- 8 grants on record
- 2015–2024 span of the record
Grants recorded here are the ones our sources publish, and the total is the sum of those. It is not a statement of this organisation's total funding.
Programmes
5 further grants are on record without a programme named by the source, or under a programme outside the largest shown here.
Frequent partners
Organisations this one has been funded alongside on two or more projects. A single shared consortium is not counted: the largest here has 195 members, and being on one list together is not a collaboration.
- BAYER AKTIENGESELLSCHAFT
- ASTRAZENECA AB
- JANSSEN PHARMACEUTICA NV
- NOVARTIS PHARMA AG
- SANOFI-AVENTIS RECHERCHE & DEVELOPPEMENT
- CHARITE - UNIVERSITAETSMEDIZIN BERLIN
- ELI LILLY AND COMPANY LTD
- MEDIZINISCHE UNIVERSITAET WIEN
Calls from this organisation
No published calls from this organisation.
Grants received
- Synthetic hEalthcare dAta goveRnanCe Hub
- INDIVIDUALISED CARE FROM EARLY RISK OF CARDIOVASCULAR DISEASE TO ESTABLISHED HEART FAILURE
- Optimal treatment for patients with solid tumours in Europe through Artificial intelligence
- Connecting digital mobility assessment to clinical outcomes for regulatory and clinical endorsement
- Big Data for Better Outcomes, Policy Innovation and Healthcare System Transformation - Sofia ref.: 116055
- ITCC Pediatric Preclinical POC Platform – Sofia ref.: 116064
- Healthcare Alliance for Resourceful Medicines Offensive against Neoplasms in HematologY - Sofia ref.: 116026
- Accelerated Development of Appropriate Patient Therapies: a Sustainable, Multi-stakeholder Approach from Research to Treatment-outcomes - Sofia ref.: 115890
Data source
© European Union, 2026. Source: CORDIS. Reused under Commission Decision 2011/833/EU — CC BY 4.0.
Retrieved from the source on .
Personal data of natural persons has been dissociated by quiescence.eu.
This service is not affiliated with, sponsored or endorsed by the data publishers.